Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer

Epidermal growth factor receptor (EGFR) is a pro-tumorigenic receptor tyrosine kinase that facilitates growth for cancer cells that overexpress the receptor. Monoclonal anti-EGFR antibody Cetuximab (CTX) provides significant clinical benefit in patients with head and neck squamous cell carcinoma (HN...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Sindhu, Trummell, Hoa Q., Rajbhandari, Rajani, Thudi, Nanda K., Nozell, Susan E., Warram, Jason M., Willey, Christopher D., Yang, Eddy S., Placzek, William J., Bonner, James A., Bredel, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028269/
https://www.ncbi.nlm.nih.gov/pubmed/32069320
http://dx.doi.org/10.1371/journal.pone.0229077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028269/
https://www.ncbi.nlm.nih.gov/pubmed/32069320
http://dx.doi.org/10.1371/journal.pone.0229077

Ejemplares similares